Insect proteins bugged by low acceptance
COMPARED to other alternative proteins, insects may be less promising – particularly beyond the research and development (R&D) stage.
According to Enterprise Singapore, about US$40 million has been invested in Singapore-based insect companies in the last four years. There are 15 such firms, with activities in more than 10 countries.
But the market is small as consumer acceptance remains low, says Asia Insect Farm Solutions co-founder Yuvanesh TS. “Everybody was going into (insect) farming, but we were all overlooking the fact that there was a market gap from farm to table. No one really took the time to understand what consumers want.”
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Opinion & Features
Singapore offices await a new wave of tenants
Musk has made Tesla a meme stock
The dog ate Japan’s plan to phase out coal power
If inflation continues to build, the Fed won’t be able to maintain neutral stance for long
Last rides and last rites: The rise of the limousine hearse
Beyond US aid, Ukraine needs European allies to step up